Rhumbline Advisers Dyne Therapeutics, Inc. Transaction History

Rhumbline Advisers

  • $121 Billion
  • Q3 2025

A detailed history of Rhumbline Advisers transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 167,820 shares of DYN stock, worth $3.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
167,820
Previous 154,541 8.59%
Holding current value
$3.16 Million
Previous $1.47 Million 44.26%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 06, 2025
BUY
$8.18 - $14.22 $108,622 - $188,827
13,279 Added 8.59%
167,820 $2.12 Million
Q2 2025

Aug 12, 2025
BUY
$6.81 - $14.78 $142,424 - $309,108
20,914 Added 15.65%
154,541 $1.47 Million
Q1 2025

Apr 08, 2025
BUY
$10.46 - $25.46 $56,306 - $137,051
5,383 Added 4.2%
133,627 $1.53 Million
Q4 2024

May 29, 2025
SELL
$23.56 - $35.55 $126,823 - $191,365
-5,383 Reduced 4.03%
128,244 $3.02 Million
Q4 2024

Jan 30, 2025
BUY
$23.56 - $35.55 $87,973 - $132,743
3,734 Added 3.0%
128,244 $3.02 Million
Q3 2024

Nov 12, 2024
BUY
$31.94 - $47.04 $93,105 - $137,121
2,915 Added 2.4%
124,510 $4.47 Million
Q2 2024

Aug 01, 2024
BUY
$23.65 - $35.63 $550,240 - $828,967
23,266 Added 23.66%
121,595 $4.29 Million
Q1 2024

May 09, 2024
BUY
$13.06 - $29.18 $288,508 - $644,615
22,091 Added 28.98%
98,329 $2.79 Million
Q4 2023

Feb 08, 2024
BUY
$6.62 - $13.64 $37,515 - $77,297
5,667 Added 8.03%
76,238 $1.01 Million
Q3 2023

Nov 09, 2023
BUY
$8.6 - $12.18 $57,267 - $81,106
6,659 Added 10.42%
70,571 $632,000
Q2 2023

Aug 08, 2023
BUY
$8.53 - $14.28 $108,603 - $181,812
12,732 Added 24.88%
63,912 $719,000
Q1 2023

May 11, 2023
BUY
$10.88 - $15.0 $21,390 - $29,490
1,966 Added 3.99%
51,180 $590,000
Q4 2022

Feb 14, 2023
BUY
$9.37 - $13.8 $3,710 - $5,464
396 Added 0.81%
49,214 $570,000
Q3 2022

Nov 10, 2022
BUY
$7.2 - $15.17 $31,939 - $67,294
4,436 Added 10.0%
48,818 $620,000
Q2 2022

Aug 11, 2022
BUY
$4.36 - $10.5 $30,249 - $72,849
6,938 Added 18.53%
44,382 $305,000
Q1 2022

May 12, 2022
SELL
$6.52 - $12.27 $4,309 - $8,110
-661 Reduced 1.73%
37,444 $361,000
Q4 2021

Feb 10, 2022
SELL
$11.89 - $16.07 $3,388 - $4,579
-285 Reduced 0.74%
38,105 $453,000
Q3 2021

Nov 12, 2021
BUY
$15.6 - $21.46 $21,840 - $30,044
1,400 Added 3.78%
38,390 $623,000
Q2 2021

Aug 05, 2021
BUY
$15.94 - $22.33 $405,545 - $568,119
25,442 Added 220.32%
36,990 $778,000
Q1 2021

May 06, 2021
BUY
$14.0 - $29.3 $161,672 - $338,356
11,548 New
11,548 $179,000

Others Institutions Holding DYN

# of Institutions
227
Shares Held
148M
Call Options Held
184K
Put Options Held
243K
View Full List

About Dyne Therapeutics, Inc.

DYN Quotes by TradingView
  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $975M
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email